Teva Pharmaceutical (Germany) Analysis
| TEV Stock | 14.65 0.40 2.66% |
Teva Pharmaceutical Industries is overvalued with Real Value of 13.6 and Hype Value of 14.65. The main objective of Teva Pharmaceutical stock analysis is to determine its intrinsic value, which is an estimate of what Teva Pharmaceutical Industries is worth, separate from its market price. There are two main types of Teva Pharmaceutical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Teva Pharmaceutical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Teva Pharmaceutical's stock to identify patterns and trends that may indicate its future price movements.
The Teva Pharmaceutical stock is traded in Germany on Stuttgart Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Teva Pharmaceutical is usually not traded on GermanUnityDay, Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, International Workers ' Day. Teva Stock trading window is adjusted to Europe/Berlin timezone.
Teva |
Teva Stock Analysis Notes
The company has price-to-book ratio of 1.18. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Teva Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 0.75. The entity had not issued any dividends in recent years.Teva Pharmaceutical Investment Alerts
| Teva Pharmaceutical generated a negative expected return over the last 90 days | |
| Teva Pharmaceutical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 14.93 B. Net Loss for the year was (2.35 B) with profit before overhead, payroll, taxes, and interest of 0. |
Teva Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.82 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Teva Pharmaceutical's market, we take the total number of its shares issued and multiply it by Teva Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 22nd of March, Teva Pharmaceutical has the Variance of 8.78, risk adjusted performance of (0.17), and Coefficient Of Variation of (506.83). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Teva Pharmaceutical, as well as the relationship between them.Teva Pharmaceutical Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Teva Pharmaceutical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Teva Pharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Teva Pharmaceutical Outstanding Bonds
Teva Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Teva Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Teva bonds can be classified according to their maturity, which is the date when Teva Pharmaceutical Industries has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| TEVA 5125 09 MAY 29 Corp BondUS88167AAQ40 | View | |
| TEVA 475 09 MAY 27 Corp BondUS88167AAP66 | View | |
| TEVA 8125 15 SEP 31 Corp BondUS88167AAR23 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Teva Pharmaceutical Predictive Daily Indicators
Teva Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Teva Pharmaceutical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Teva Pharmaceutical Forecast Models
Teva Pharmaceutical's time-series forecasting models are one of many Teva Pharmaceutical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Teva Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Teva Pharmaceutical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Additional Tools for Teva Stock Analysis
When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.